RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 8 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $12,489 | -59.7% | 71,366 | -0.2% | 0.00% | – |
| Q3 2022 | $31,000 | -49.2% | 71,493 | 0.0% | 0.00% | – |
| Q2 2022 | $61,000 | -97.3% | 71,493 | -82.7% | 0.00% | – |
| Q1 2022 | $2,273,000 | -46.1% | 412,525 | -5.3% | 0.00% | -100.0% |
| Q4 2021 | $4,217,000 | -47.4% | 435,677 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $8,019,000 | -30.8% | 448,459 | -5.6% | 0.00% | -50.0% |
| Q2 2021 | $11,592,000 | +10.1% | 474,841 | +19.5% | 0.00% | 0.0% |
| Q1 2021 | $10,532,000 | +238.3% | 397,413 | -3.1% | 0.00% | +100.0% |
| Q4 2020 | $3,113,000 | +47.6% | 410,024 | -2.6% | 0.00% | – |
| Q3 2020 | $2,109,000 | -19.6% | 420,872 | -4.0% | 0.00% | -100.0% |
| Q2 2020 | $2,622,000 | +30.0% | 438,447 | -3.3% | 0.00% | 0.0% |
| Q1 2020 | $2,017,000 | -52.5% | 453,313 | +1.5% | 0.00% | 0.0% |
| Q4 2019 | $4,243,000 | +20.8% | 446,648 | -0.2% | 0.00% | 0.0% |
| Q3 2019 | $3,512,000 | -41.2% | 447,433 | +17.8% | 0.00% | 0.0% |
| Q2 2019 | $5,977,000 | -10.1% | 379,917 | +3.5% | 0.00% | -50.0% |
| Q1 2019 | $6,645,000 | +141.3% | 367,164 | +114.4% | 0.00% | +100.0% |
| Q4 2018 | $2,754,000 | -14.7% | 171,245 | +27.3% | 0.00% | 0.0% |
| Q3 2018 | $3,230,000 | – | 134,571 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |